End-of-day quote
Taipei Exchange
03:30:00 03/05/2024 am IST
5-day change
1st Jan Change
253.5
TWD
-0.98%
+5.62%
-8.48%
Universal Vision Biotechnology Co., Ltd. Announces Expiration for the 4Th Term of the Remuneration Committee of the Company
August 27, 2021 at 04:07 pm IST
Universal Vision Biotechnology Co., Ltd. announced of the expiration for the 4th term of the remuneration committee of the company effective August 27, 2021. Name of the previous position holder: Yan-Jun Chen; Min-Zhi Xiao; and Vincent Liu. Reason for the change: The term of the Remuneration Committee shall be the same as the term of the Board of Directors re-elected in the 2021 annual general meeting.
Universal Vision Biotechnology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023
14/03
CI
Universal Vision Biotechnology Co., Ltd. Declares Cash Dividend, Payable on May 20, 2024
13/03
CI
Universal Vision Biotechnology Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
13/11
CI
Universal Vision Biotechnology Co., Ltd. Announces Cash Dividend, Payable on September 20, 2023
10/23/10
CI
Universal Vision Biotechnology Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
10/23/10
CI
Universal Vision Biotechnology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
17/23/17
CI
Universal Vision Biotechnology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022
28/23/28
CI
Health Care Down on Mixed Earnings Prospects - Health Care Roundup
18/23/18
DJ
Universal Vision Biotechnology Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
11/22/11
CI
Universal Vision Biotechnology Co., Ltd. Announces Principal Financial and Accounting Officer Changes
20/22/20
CI
Universal Vision Biotechnology Co., Ltd. Announces Change of the Principal Financial and Accounting Officer
12/22/12
CI
Universal Vision Biotechnology Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
11/22/11
CI
Universal Vision Biotechnology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022
12/22/12
CI
Universal Vision Biotechnology Co., Ltd. Announces Dividend, Payable on May 13, 2022
30/22/30
CI
Universal Vision Biotechnology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021
30/22/30
CI
Universal Vision Biotechnology Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021
11/21/11
CI
Universal Vision Biotechnology Co., Ltd. Announce Audit Committee Appointment
27/21/27
CI
Universal Vision Biotechnology Co., Ltd. Announces Expiration for the 4Th Term of the Remuneration Committee of the Company
27/21/27
CI
Universal Vision Biotechnology Co., Ltd. Reports Earnings Results for the Second Quarter Ended June 30, 2021
11/21/11
CI
Universal Vision Biotechnology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2021
12/21/12
CI
Universal Vision Biotechnology Co., Ltd. Announces Cash Dividend Payable on May 13, 2021
24/21/24
CI
Universal Vision Biotechnology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2020
24/21/24
CI
Universal Vision Biotechnology Co., Ltd. Reports Earnings Results for the Third Quarter Ended September 30, 2020
12/20/12
CI
Universal Vision Biotechnology Co., Ltd.(GTSM:3218) added to S&P Global BMI Index
21/20/21
CI
Universal Vision Biotechnology Co., Ltd. Reports Earnings Results for the Second Quarter Ended June 30, 2020
12/20/12
CI
Duration Auto. 2 months 3 months 6 months 9 months 1 year 2 years 5 years 10 years Max.
Period Day Week
More charts
UNIVERSAL VISION BIOTECHNOLOGY CO., LTD is a Taiwan-based company principally engaged in the trading of ophthalmic supplies and the provision of eye treatment and related medical services. The Company provides laser vision correction equipment and services, as well as the trading of medical drugs, optical glasses and contact lenses. In addition, the Company is involved in the leasing of medical places, the planning of clinic operation, as well as the provision of medical cosmetology services. The Company operates its businesses mainly in Taiwan market.
More about the company
Last Close Price
253.5
TWD
Average target price
313.8
TWD
Spread / Average Target
+23.77%
Consensus
1st Jan change
Capi.
-8.48% 665M +11.23% 98.38B +9.93% 39.34B -4.20% 18.02B -16.61% 2.33B -10.04% 1.51B +26.36% 1.21B -34.97% 755M -36.42% 744M +26.67% 509M
Glasses, Spectacles & Contact Lenses
+951% of historical performance
More than 20 years at your side
Our Experts are here for you
OUR EXPERTS ARE HERE FOR YOU
Monday - Friday 9am-12pm / 2pm-6pm GMT + 1